Prevalence of dyslipidemia risk factors and hypertension in pre and postmenopause according to treatment exposure(1, 2, 3, 4, 5)
| Metabolic risk | Newly-diagnosed (N = 134) | Recently-diagnosed (N = 262) | Whole sample (N = 396) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premeno-pause (N = 80) | Postmeno-pause (N = 54) | Premeno-pause (N = 149) | Postmeno-pause (N = 113) | Premeno-pause (N = 229) | Postmeno-pause (N = 167) | |||||||
| n | % | n | % | n | % | n | % | n | % | n | % | |
| SBP* (mmHg) | 6 | 4.5 | 8 | 6.0 | 13 | 5.0 | 29 | 11.1 | 19 | 4.8 | 37 | 9.3 |
| DBP* (mmHg) | 8 | 6.0 | 16 | 11.9 | 20 | 7.6 | 29 | 11.1 | 28 | 7.1 | 45 | 11.4 |
| HDL* (mg/dl) | 48 | 35.8 | 34 | 25.4 | 104 | 39.7 | 78 | 29.9 | 152 | 38.4 | 112 | 28.3 |
| TG* (mg/dl) | 56 | 41.8 | 46 | 34.3 | 116 | 44.3 | 100 | 38.3 | 172 | 43.4 | 146 | 36.9 |
Prevalence of the dyslipidemia risk factors and hypertension according to treatment exposure(1, 2, 3, 4)
| Variables | Cut-off points | Newly diagnosed (n = 134) | Recently – diagnosed (n = 262) | Whole sample (n = 396) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-chemo (n = 86) | Chemo (n = 176) | Total (n = 262) | |||||||||
| n | % | n | % | n | % | n | % | n | % | ||
| SBP (mmHg) | > 130 | 14 | 10.4a | 8 | 9.3a | 34 | 19.3b | 42 | 16.0b | 56 | 14.1 |
| DBP (mmHg) | > 85 | 24 | 17.9a | 11 | 12.8a | 38 | 21.6a | 49 | 18.7a | 73 | 18.4 |
| Overt hypertension* | 31 | 23.1 | 10 | 11.6 | 49 | 27.8 | 59 | 22.5 | 90 | 22.7 | |
| HDL-C (mg/dl) | < 50 | 82 | 61.2a | 70 | 81.4b | 112 | 63.6a | 182 | 69.5b | 264 | 66.7 |
| TG (mg/dl) | > 150 | 102 | 76.1a | 73 | 84.9b | 143 | 81.2b | 216 | 82.4b | 318 | 80.3 |
| TC (mg/dl) | > 200 | 90 | 67.2a | 75 | 87.2b | 137 | 77.8b | 212 | 80.9b | 302 | 76.3 |
| Overt dyslipidemia* | 7 | 5.2 | 2 | 2.3 | 10 | 5.7 | 12 | 4.6 | 19 | 4.8 | |
Dyslipidemia and hypertension characteristic in pre and postmenopause women according to treatment exposure(1, 2, 3, 4, 5)
| Metabolic risks | Newly-diagnosed (N = 134) | Recently-diagnosed (N = 262) | Whole sample (N = 396) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premeno-pause (N = 80) | Postmeno-pause (N = 54) | Premeno-pause (N = 149) | Postmeno-pause (N = 113) | Premeno-pause (N = 229) | Postmeno-pause (N = 167) | |||||||
| Mean ± SEM | Mean ± SEM | Mean ± SEM | Mean ± SEM | Mean ± SEM | Mean ± SEM | |||||||
| SBP*(mmHg) | 117.1 | 1.5 | 121.1 | 1.7a | 118.5 | 0.9 | 136.2 | 1.2b | 118.0 | 0.8 | 129.3 | 1.0 |
| DBP(mmHg) | 76.6 | 1.4 | 80.9 | 1.1 | 78.3 | 0.6 | 80.2 | 1.0 | 78.0 | 0.6 | 80.0 | 0.7 |
| HDL-C(mg/dl) | 47.9 | 0.9 | 47.7 | 1.6 | 44.8 | 0.8 | 46.7 | 0.9 | 46.0 | 0.6 | 47.0 | 0.8 |
| TG* (mg/dl) | 182.5 | 6.9 | 215.3 | 9.6 | 201.7 | 6.1 | 223.5 | 7.4 | 195.0 | 4.7 | 221.0 | 5.9 |
Dyslipidaemia and hypertension characteristics according to treatment exposure(1, 2, 3)
| Character | Newly-diagnosed (n = 134) | Recently – diagnosed (n=262) | Whole sample (n = 396) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Non-chemo (n = 86) | Chemo (n = 176) | Total (n = 262) | ||||||||
| Mean ± SEM | Mean ± SEM | Mean ± SEM | Mean ± SEM | Mean ± SEM | ||||||
| SBP (mmHg) | 119.1 | 1.1a | 119.5 | 1.2a | 123.0 | 0.9b | 121.9 | 0.8a | 120.9 | 0.6 |
| DBP (mmHg) | 78.4 | 1.0a | 78.0 | 0.8a | 79.6 | 0.7a | 79.1 | 0.5a | 78.8 | 0.5 |
| HDL-C(mg/dl) | 47.8 | 0.8a | 42.9 | 1.0b | 47.6 | 0.7a | 45.6 | 0.6b | 46.4 | 0.5 |
| LDL-C (mg/dl) | 126.9 | 9.0a | 141.0 | 3.4a | 128.8 | 2.8a | 132.8 | 2.2a | 130.8 | 3.4 |
| TG (mg/dl) | 195.7 | 5.8a | 221.8 | 8.9b | 205.9 | 5.6b | 211.1 | 4.7b | 205.9 | 3.7 |
Age-controlled partial correlation coefficients of dyslipidemia risk factors and hypertension with obesity indices and selected biomarkers in the study sample(1–2)
| Metabolic risks | BMI | WC | WHpR | WHtR | leptin | HOMA | C-peptide |
|---|---|---|---|---|---|---|---|
| SBR(mmHg) | 0.04 | 0.08 | 0.12 | 0.08 | 0.10 | 0.14** | 0.03 |
| DBR (mmHg) | 0.01 | 0.17*** | 0.15** | 0.13* | 0.08 | 0.10* | −0.02 |
| HDL-C(mg/dl) | −0.11* | −0.11* | −0.09 | −0.13** | −0.02 | 0.02 | 0.03 |
| TG (mg/dl) | 0.05 | 0.16*** | 0.08 | 0.15** | −0.11* | 0.03 | 0.02 |